Improvement of survival in Wilms Tumor patients at the paediatric oncology unit, KATH
DOI:
https://doi.org/10.31191/afrijcmr.v5i1.103Keywords:
Wilms Tumor, Global Initiative for Childhood Cancer, KATH, GhanaAbstract
Background
Wilms Tumor (WT) is one of the common and curable cancer types targeted by the World Health Organization (WHO) Global initiative for childhood cancer (GICC). Although, survival in high income countries is good, the same cannot be said of survival in low- and middle-income countries (LMIC) like Ghana. The main aim of this study was to determine the clinical presentation and survival of patients with WT presenting at the Komfo Anokye Teaching Hospital
Methods
This research is a 5-year (2016 - 2020) prospective hospital based cross sectional study. Patient characteristics, tumor characteristics and outcome were described, and survival analysis was done. The survival was compared to a historical cohort (2011- 2013) which was evaluated in 2015 where 18.5% of patients survived.
Results
A total of 51 patients were seen over the 5-year period with a male to female ratio of 1.2:1. The median age of presentation was 3years. Majority of patients (56.5%) presented with a left sided renal mass. A significant proportion presented with Stage III (37.1%) and Stage IV (20.98%) disease. The commonest site of metastasis was the liver with 19.4% of patients presenting with it. Thirty three percent (33%) of the patients died with 8(47%) occurring before initiation of treatment. Mortality was highest amongst patients with advanced disease with a p-value of 0.19. The 3-year event free survival with abandonment as an event in patients seen from 2016 - 2019 was 55.6% (p-0.026).
Conclusion
Patients with high stage tumors (Stage III and IV) were at a higher risk of death as compared to the patients with lower stage tumors. Early detection and treatment of patients with WT can lead to a favorable outcome.
References
N/A
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under the Creative Commons Attribution License CC BY-NC-ND that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
